These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 21225235)
1. Penetration of paclitaxel and 5-fluorouracil in multicellular layers of human colorectal cancer cells. Choi MS; Kim SH; Kuh HJ Oncol Rep; 2011 Mar; 25(3):863-70. PubMed ID: 21225235 [TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro. Lee JW; Park JK; Lee SH; Kim SY; Cho YB; Kuh HJ Anticancer Drugs; 2006 Apr; 17(4):377-84. PubMed ID: 16549994 [TBL] [Abstract][Full Text] [Related]
3. Effect of paclitaxel priming on doxorubicin penetration in a multicellular layer model of human colorectal cancer cells. Kim KS; Kim SH; Im CN; Na K; Lee MY; Park JK; Kuh HJ Biochem Biophys Res Commun; 2023 Mar; 647():30-36. PubMed ID: 36709670 [TBL] [Abstract][Full Text] [Related]
4. The distribution and retention of paclitaxel and doxorubicin in multicellular layer cultures. Lee JH; Na K; Song SC; Lee J; Kuh HJ Oncol Rep; 2012 Apr; 27(4):995-1002. PubMed ID: 22267208 [TBL] [Abstract][Full Text] [Related]
5. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Grantab R; Sivananthan S; Tannock IF Cancer Res; 2006 Jan; 66(2):1033-9. PubMed ID: 16424039 [TBL] [Abstract][Full Text] [Related]
6. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines. Bjelogrlić SK; Srdić T; Radulović S J BUON; 2007; 12(1):71-6. PubMed ID: 17436405 [TBL] [Abstract][Full Text] [Related]
7. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of interstitial protein delivery in multicellular layers model. Kim SY; Kim TH; Choi JH; Lee KC; Park KD; Lee SJ; Kuh HJ Arch Pharm Res; 2012 Mar; 35(3):531-41. PubMed ID: 22477201 [TBL] [Abstract][Full Text] [Related]
9. Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel. Al-Abd AM; Lee JH; Kim SY; Kun N; Kuh HJ Cancer Sci; 2008 Feb; 99(2):423-31. PubMed ID: 18271941 [TBL] [Abstract][Full Text] [Related]
10. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase. Réti A; Pap E; Adleff V; Jeney A; Kralovánszky J; Budai B Cancer Chemother Pharmacol; 2010 Jul; 66(2):219-27. PubMed ID: 19830428 [TBL] [Abstract][Full Text] [Related]
11. Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors. Tunggal JK; Cowan DS; Shaikh H; Tannock IF Clin Cancer Res; 1999 Jun; 5(6):1583-6. PubMed ID: 10389947 [TBL] [Abstract][Full Text] [Related]
12. Non-nuclear localization of Ki-67 in human colorectal cancer cells grown as multicellular layers. Kim YJ; Lee SH; Lee J; Kuh HJ Arch Pharm Res; 2013 May; 36(5):634-40. PubMed ID: 23536320 [TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles. Stutchbury TK; Vine KL; Locke JM; Chrisp JS; Bremner JB; Clingan PR; Ranson M Anticancer Drugs; 2011 Jan; 22(1):24-34. PubMed ID: 20881836 [TBL] [Abstract][Full Text] [Related]
14. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor. Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530 [TBL] [Abstract][Full Text] [Related]
15. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing. Zhang X; Wang W; Yu W; Xie Y; Zhang X; Zhang Y; Ma X Biotechnol Prog; 2005; 21(4):1289-96. PubMed ID: 16080713 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. Serpe L; Catalano MG; Cavalli R; Ugazio E; Bosco O; Canaparo R; Muntoni E; Frairia R; Gasco MR; Eandi M; Zara GP Eur J Pharm Biopharm; 2004 Nov; 58(3):673-80. PubMed ID: 15451544 [TBL] [Abstract][Full Text] [Related]
17. The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel. Sakashita F; Osada S; Takemura M; Imai H; Tomita H; Nonaka K; Takahashi T; Seishima M Cancer Chemother Pharmacol; 2008 Aug; 62(3):379-85. PubMed ID: 17960385 [TBL] [Abstract][Full Text] [Related]
18. Polymer chemotherapy for head and neck cancer. Shikani AH; Domb AJ Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503 [TBL] [Abstract][Full Text] [Related]
19. A mathematical model of doxorubicin penetration through multicellular layers. Evans CJ; Phillips RM; Jones PF; Loadman PM; Sleeman BD; Twelves CJ; Smye SW J Theor Biol; 2009 Apr; 257(4):598-608. PubMed ID: 19183560 [TBL] [Abstract][Full Text] [Related]
20. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]